GS

Girish Shahi

Active Director Director DIN 00926966
DIN 00926966 First appointment Oct 1979 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 1979
Shareholding value •••• Premium profile

About Girish Shahi

Data last updated:

Girish Shahi is a Director at Bio Nova Pharmaceuticals Pvt Ltd (since 1979). The company operates in Pharma. Bio Nova Pharmaceuticals Pvt Ltd reported revenue of ₹2.28 Cr (FY 2025).

DIN 00926966
Primary Designation Director
Industry Pharma
First Appointment 25 Oct 1979
Oldest Company Age 47 yrs
Largest company Bio Nova Pharmaceuticals Pvt Ltd · ₹2.28 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bio Nova Pharmaceuticals Pvt Ltd U74899DL1979PTC009956
Director25 Oct 19791979₹2.28 Cr (FY 2025)Active

Board colleagues of Girish Shahi

NameDINCompanyDesignation
Alpana Shahi07111091Bio Nova Pharmaceuticals Pvt LtdDirector

Directorship timeline

Open interactive timeline →
Bio Nova Pharmaceuticals Pvt Ltd
Premium access

Shareholding and investment profile for Girish Shahi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Girish Shahi

Girish Shahi currently holds 1 directorship: Bio Nova Pharmaceuticals Pvt Ltd (Director, since 25 Oct 1979, revenue ₹2.28 Cr (FY 2025)).

Girish Shahi was first appointed on 25 Oct 1979 as Director at Bio Nova Pharmaceuticals Pvt Ltd.

The current boards of Girish Shahi's companies include Alpana Shahi (Bio Nova Pharmaceuticals Pvt Ltd).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available